Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African Women: A randomized, placebo-controlled trial

Sexually Transmitted Diseases

Volumn 39, Issue 1, 2012, Pages 21-24

  Baeten, Jared M ^a   Reid, Stewart E ^b,c   Delany Moretlwe, Sinead ^d   Hughes, James P ^a   Wang, Richard S ^a   Wilcox, Ellen ^a   Limbada, Mohammed ^c   Akpomiemie, Godspower ^d   Corey, Lawrence ^a,e   Wald, Anna ^a,e   Celum, Connie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Alabama at Birmingham   (United States)

^c CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PLACEBO;

ADULT; ANTIVIRAL THERAPY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPITHELIZATION; FEMALE; FOLLOW UP; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 2; HUMAN; NEGRO; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; ULCER HEALING; VIRUS SHEDDING;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV SERONEGATIVITY; HIV-1; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; RECURRENCE; SEROEPIDEMIOLOGIC STUDIES; SOUTH AFRICA; ULCER; VIRUS SHEDDING; ZAMBIA;

EID: 83555164949     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31823b50c6     Document Type: Review

References (16)

1. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83. (Pubitemid 41818117)
2. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571. (Pubitemid 351519816)
3. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomized, double-blind, placebo-controlled trial. Lancet 2008; 371: 2109-2119. (Pubitemid 351902179)
4. Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004; 190:1374-1381. (Pubitemid 39332176)
5. Fuchs J, Celum C, Wang J, et al. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial. J Infect Dis 2010; 201:1164-1168.
6. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva, Switzerland: World Health Organization, 2003.
7. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. Morb Mortal Wkly Rep 2006; 55:1-94.
8. Jerome KR, Huang ML, Wald A, et al. Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. J Clin Microbiol 2002; 40:2609-2611. (Pubitemid 34747371)
9. Nilsen AE, Aasen T, Halsos AM, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet 1982; 2:571-573. (Pubitemid 12049485)
10. Bryson YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med 1983; 308:916-921. (Pubitemid 13110423)
11. Bavaro JB, Drolette L, Koelle DM, et al. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection. Sex Transm Dis 2008; 35:383-386. (Pubitemid 351440780)
12. Zhu J, Hladik F, Woodward A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009; 15:886-892.
13. Paz-Bailey G, Sternberg M, Puren AJ, et al. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: A randomized, controlled trial. J Infect Dis 2009; 200:1039-1049.
14. Phiri S, Hoffman IF, Weiss HA, et al. Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi. Sex Transm Infect 2010; 86:345-352.
15. Mayaud P, Legoff J, Weiss HA, et al. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: A randomized placebo-controlled trial. J Infect Dis 2009; 200:216-226.
16. Corbell C, Stergachis A, Ndowa F, et al. Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries. Sex Transm Dis 2010; 37:488-493.